Name: UMIN ID:
Unique ID issued by UMIN | UMIN000005424 |
---|---|
Receipt number | R000006341 |
Scientific Title | Adjuvant chemotherapy with TS-1 administered 5-days on/ 2-days off Schedule for Gastric or Colorectal cancer. |
Date of disclosure of the study information | 2011/04/12 |
Last modified on | 2022/04/20 11:55:51 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/04/12 14:04:38 | ||
2 | Update | 2013/10/15 11:20:22 | Email Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
3 | Update | 2014/04/14 13:45:09 | Last name of lead principal investigator Last name of lead principal investigator Organization Organization Organization Organization Homepage URL Organization Organization Institute Institute Organization1 Email1 Institutions |
|
4 | Update | 2015/11/04 14:25:12 | Recruitment status |
|
5 | Update | 2016/04/12 15:56:44 | Last name of lead principal investigator Last name of lead principal investigator Name of primary person or sponsor Organization |
|
6 | Update | 2019/10/18 11:55:52 | Control |
|
7 | Update | 2019/10/18 12:02:18 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization1 Organization Organization Address Address Tel |
|
8 | Update | 2019/10/18 12:03:14 | Number of participants that the trial has enrolled |
|
9 | Update | 2019/10/18 12:05:21 | Date of IRB Last follow-up date |
|
10 | Update | 2022/04/20 11:52:07 | Recruitment status Date of closure to data entry Other related information |
|
11 | Update | 2022/04/20 11:55:51 | URL releasing protocol URL related to results and publications Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |